🧫
experiment

Participants carrying the APOE epsilon 4 allele showed more rapid biomarker changes (decreasing Aβ42:Aβ40 and increasing p-tau181, NfL, GFAP) from midlife to late life compared to non-carriers.

🧫 Experiment Protocol Genetic AssociationAlzheimer's diseaseAPOEhumanextracted
APOE genotyping performed; stratification by ε4 carrier status.
PRIMARY OUTCOME
Participants carrying the APOE epsilon 4 allele showed more rapid biomarker changes (decreasing Aβ42:Aβ40 and increasing p-tau181, NfL, GFAP) from midlife to late life compared to non-carriers.
LINKED HYPOTHESES
Source: pmid_39068543
🧫 Experiment Extras
PATHWAY
lipid metabolism
MARKET PRICE
$0.50
STATUS
extracted
Related Target
APOEcomposite 0.621
View on SciDEX ↗